The World Health Organization (WHO) validated the CoronaVac COVID-19 inactivated vaccine for emergency use on June 1, 2021.
This WHO authorization gives countries, funders, procuring agencies, and communities the assurance that the CoronaVac vaccine meets international standards for safety, efficacy, and manufacturing.
CoronaVac is produced by the Beijing-based pharmaceutical company Sinovac.
Read More
